Exousia Bio (LMMY) Enterprise Value (2022 - 2024)
Lamy (LMMY) has disclosed Enterprise Value for 3 consecutive years, with -$1028.0 as the latest value for Q4 2024.
- Quarterly Enterprise Value changed 0.0% to -$1028.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$1028.0 through Nov 2024, changed 0.0% year-over-year, with the annual reading at -$1028.0 for FY2024, 86.91% up from the prior year.
- Enterprise Value hit -$1028.0 in Q4 2024 for Lamy, roughly flat from -$1028.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1028.0 in Q4 2023 to a low of -$7855.0 in Q2 2023.
- Historically, Enterprise Value has averaged -$2203.1 across 3 years, with a median of -$1028.0 in 2023.
- Biggest YoY gain for Enterprise Value was 86.91% in 2024; the steepest drop was 0.0% in 2024.
- Year by year, Enterprise Value stood at -$1351.0 in 2022, then rose by 23.91% to -$1028.0 in 2023, then changed by 0.0% to -$1028.0 in 2024.
- Business Quant data shows Enterprise Value for LMMY at -$1028.0 in Q4 2024, -$1028.0 in Q3 2024, and -$1028.0 in Q2 2024.